Literature DB >> 3297570

Single or multiple doses of metronidazole and ampicillin in elective colorectal surgery. A randomized trial.

P Juul, K E Klaaborg, O Kronborg.   

Abstract

A randomized trial including 294 patients was performed to evaluate the prophylactic effect of single vs. multiple doses of antibiotics in elective colorectal surgery. All patients received 1.5 g metronidazole and 3.0 g ampicillin peroperatively and were randomized to: no further prophylactic antibiotic treatment, or ampicillin 1 g X 3 and metronidazole 0.5 g X 3 given intravenously during the second and third postoperative days. Deep wound infection was seen in 9/149 (6 percent) receiving a single dose and in 8/145 (6 percent) receiving multiple doses. No differences were found in the two groups between frequencies of anastomotic dehiscences, intra-abdominal abscesses, sepsis, and pulmonary infections. The two groups were similar according to distribution of sex, age, diagnosis, and type of surgery. A single peroperative dose of metronidazole and ampicillin is a simple and satisfactory antibiotic prophylaxis in elective colorectal surgery.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3297570     DOI: 10.1007/BF02554782

Source DB:  PubMed          Journal:  Dis Colon Rectum        ISSN: 0012-3706            Impact factor:   4.585


  4 in total

1.  Septic complications of elective laparoscopic colorectal resection.

Authors:  E C Poulin; C M Schlachta; P A Seshadri; M O Cadeddu; R Grégoire; J Mamazza
Journal:  Surg Endosc       Date:  2001-02       Impact factor: 4.584

2.  Prophylaxis in elective colorectal surgery: the cost of ignoring the evidence.

Authors:  Naureen Wasey; James Baughan; C J de Gara
Journal:  Can J Surg       Date:  2003-08       Impact factor: 2.089

3.  A randomized trial of one versus three doses of Augmentin as wound prophylaxis in at-risk abdominal surgery.

Authors:  T Bates; J V Roberts; K Smith; K A German
Journal:  Postgrad Med J       Date:  1992-10       Impact factor: 2.401

4.  Short-term intravenous antimicrobial prophylaxis for elective rectal cancer surgery: results of a prospective randomized non-inferiority trial.

Authors:  Keiichiro Ishibashi; Hideyuki Ishida; Kouki Kuwabara; Tomonori Ohsawa; Norimichi Okada; Masaru Yokoyama; Kensuke Kumamoto
Journal:  Surg Today       Date:  2013-08-29       Impact factor: 2.549

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.